Business

Abbott said Exact Sciences will operate as a subsidiary following the transaction. The acquisition adds a business generating more than $3bn in annual revenue to Abbott’s diagnostics portfolio.

Danaher paid $9.9bn for Masimo. Abbott committed to Exact Sciences. Boston Scientific reached for Penumbra. Medtronic accelerated on multiple fronts. The window medtech spent two years waiting for is open – and the industry is moving through it fast.

The combined entity will employ more than 20,000 people across more than 100 countries, hold close to 3,000 patents, and bring together more than 700 R&D professionals.

Paradromics has launched a new academic-industry collaboration with leading brain-computer interface researchers at Stanford, Mass General, Pitt, UC Davis and Michigan aiming to translate BCI research into devices to help people with speech impairment, stroke and Parkinson’s.

Google spinout Verily has raised $300m to advance its AI-driven personalized healthcare platforms and become an independent company.

Vitestro raised an oversubscribed $70M Series B to scale its autonomous blood-drawing system across the Netherlands and expand into Europe. The CE-marked robot has been tested in more than 10,000 patients, and the company is pursuing FDA clearance to enter the US market.

Cognito Therapeutics closed a new funding round to advance its Alzheimer’s headset toward FDA De Novo submission and planned 2027 launch while expanding its Brain Health Collaboratory to support adoption, reimbursement innovation, and pipeline growth.

breaking news

Health tech start-up Solace Health raised $130m in a series C funding round, which will allow it to expand its national network of more than 2,000 advocates serving Medicare and Medicare Advantage members.

Advocates spanning the spectrum of women’s health met in Manhattan to discuss the gender disparities that remain in healthcare and how public policy can correct them and the enormous ROI investors in women’s health can potentially reap.

US FDA inspections of three Philips manufacturing sites earlier this year resulted in a September warning letter that claimed the company was not in conformity with current good manufacturing practices. Philips says it is addressing the agency’s concerns and working to enhance its quality systems.

Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.

Faction Imaging has come out of stealth mode following six years of research and development studying medical imaging workflows in India, Japan and the US.

The US Congress overwhelmingly passed legislation reauthorizing federal programs essential to smaller medtech firms in need of funding. AdvaMed says the bill is critical for medtech innovation.

Cognito Therapeutics has revealed data from its OVERTURE feasibility study backing up the ability of its non-invasive Spectris headset to treat Alzheimer’s via the stimulation of gamma oscillations. The company is hoping to launch the device in 2027

The FDA approved JenaValve’s Trilogy HeartValve for treating severe aortic regurgitation, marking it as the first TAVR device for this condition in the US. The approval, which followed promising clinical results, is significant for patients with limited options due to high surgical risks.

The global medical device market reached $623.37 billion in 2026 and should exceed $1.08 trillion by 2035. Despite this explosive growth, the journey from research and development to commercialization remains fraught with regulatory complexities, evolving market dynamics, and technical disruptions.

The US Congress overwhelmingly passed legislation reauthorizing federal programs essential to smaller medtech firms in need of funding. AdvaMed says the bill is critical for medtech innovation.

The global medical device market reached $623.37 billion in 2026 and should exceed $1.08 trillion by 2035. Despite this explosive growth, the journey from research and development to commercialization remains fraught with regulatory complexities, evolving market dynamics, and technical disruptions.

The US Medicare agency is now covering superficial radiotherapy (SRT) for the treatment of skin cancer. Joseph Sardano, CEO of SRT firm Sensus Healthcare, spoke to Medtech Insight about the potential of the technology and why it’s still facing adaptation challenges.

With capital being recycled, tariffs settling and interest rates softening, 2026 could provide more investment and growth opportunities in pharma and medtech, with AI giving a tailwind, say Taylor Wessing’s Ross McNaughton and Sarah Cole.